Sudarshan Pharma Industries
add_icon

Sudarshan Pharma Industries

40.25
+0.34
(0.85%)
Market Cap
1,004.89 Cr
PE Ratio
39.91
Volume
2,44,000.00
Day High - Low
40.25 - 38.35
52W High-Low
42.79 - 18.50
ann
There are 3 new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,004.89 Cr
EPS
0.97
PE Ratio
39.91
PB Ratio
5.85
Book Value
6.82
EBITDA
51.32
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
12.13
Debt to Equity
1.13
Forecast For
Actual

Company News

View All News
Caret
neutral
Sudarshan Pharma Industries schedules 18th AGM for September 22, 2026. Dr. Anil Ghogare seeks re-appointment as non-executive director.
neutral
Hemal V Mehta and Sachin V Mehta pledged 66.50 lakh shares each with Satin Finserv on Aug 25, 2026. Total encumbered promoter holding rises to 5.21% for both.
neutral
Promoters Hemal V Mehta and Sachin V Mehta pledged 66 lakh shares each, totaling 2.64% stake per promoter, to secure loans for Sudarshan Pharma Industries.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,256.90
#1 9,882.70
111.71
#1 9,866.40
#1 191.99
41
88.00
72.35
492.90
3,212.13
#1 0.54
839.65
-1.78
#1 5,444
#1 2,778.22
65.26
617.85
1,723.08
769.94
169.39
-5.26
2
57.14
-
451.40
1,459.72
20.33
976.63
19.52
74
9.05
65.48
99.08
1,247.85
17.24
2,012.24
14.55
57
220.00
85.91
411.30
1,201.00
13.41
786.40
11.21
81
56.44
54.63
238.75
1,042.00
14.63
880.80
46.41
45
211.01
71.80
40.25
#8 1,004.89
#7 39.91
#8 703.06
#3 38.51
#8 23
#8 40.00
59.92
390.35
901.00
18.29
807.50
-4.30
45
19.30
50.09
266.70
508.21
60.60
175.40
7.54
7
92.31
59.56
Growth Rate
Revenue Growth
38.51 %
Net Income Growth
45.13 %
Cash Flow Change
486.02 %
ROE
18.34 %
ROCE
32.57 %
EBITDA Margin (Avg.)
-13.76 %

Quarterly Financial Results

Quarterly Financials
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
232
100
129
116
162
147
171
170
225
176
Expenses
217
97
117
108
147
134
160
157
201
159
EBITDA
15
3
12
9
15
12
11
12
24
17
Operating Profit %
6 %
2 %
9 %
7 %
9 %
8 %
5 %
6 %
9 %
9 %
Depreciation
1
1
1
1
1
1
1
1
1
1
Interest
6
4
4
4
4
6
6
6
8
8
Profit Before Tax
9
-2
8
4
10
5
4
5
16
8
Tax
2
-0
2
1
3
1
0
1
4
2
Net Profit
7
-1
6
3
7
4
4
4
11
6
EPS in ₹
0.27
-0.05
0.24
0.12
0.29
0.16
0.16
0.18
0.48
0.23

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
58
99
138
233
283
402
642
Fixed Assets
6
6
7
20
26
24
102
Current Assets
47
88
130
199
242
335
490
Capital Work in Progress
0
0
1
0
2
6
3
Investments
0
0
0
0
2
2
219
Other Assets
53
93
131
213
254
371
0
Total Equity & Liabilities
58
99
138
233
283
402
642
Current Liabilities
31
71
103
119
161
260
456
Non Current Liabilities
7
6
5
13
11
11
29
Total Equity
20
23
30
101
112
132
155
Reserve & Surplus
10
13
20
77
88
104
131
Share Capital
10
10
10
24
24
24
24

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-2
0
-1
12
-12
0
Investing Activities
-3
-1
-2
-26
-6
-20
Operating Activities
1
3
-4
-29
6
35
Financing Activities
-0
-2
4
66
-12
-14

Share Holding

% Holding
Mar 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Aug 2026
Promoter
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
57.39 %
58.93 %
58.93 %
FIIs
0.00 %
1.40 %
1.40 %
13.07 %
18.45 %
19.48 %
20.79 %
19.78 %
19.95 %
19.38 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.05 %
0.05 %
0.05 %
0.05 %
0.05 %
Public / Retail
20.35 %
27.04 %
23.61 %
23.20 %
18.18 %
17.14 %
16.30 %
16.88 %
16.41 %
16.37 %
17.27 %
Others
22.26 %
14.16 %
17.59 %
6.33 %
5.98 %
5.94 %
5.46 %
5.90 %
6.20 %
5.27 %
23.75 %
No of Share Holders
2,785
983
913
787
1,212
1,327
1,383
1,407
1,346
1,231
1,217

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.3 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 4.05 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Aug 2023 DIVIDEND Dividend
₹ 0.30 /share
25 Aug 2023 6.75 8.15
05 Feb 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
05 Feb 2024 7.53 7.71
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 41.89 41.86
30 Sept 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Sept 2024 21.52 41.86
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2024 35.30 38.48
23 Nov 2024 SPLIT Split
1:10
23 Nov 2024 41.86 43.95
04 Feb 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Feb 2025 49.79 40.30
24 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Apr 2025 29.53 27.81
12 Jun 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Jun 2025 29.98 31.22
25 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Jul 2025 29.22 26.65
11 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
11 Aug 2025 29.20 30.00
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 30.00 30.00
18 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Oct 2025 27.55 26.90
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2026 19.41 19.23
30 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Apr 2026 30.29 30.00
12 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2026 34.00 33.91

Announcements

Reg. 34 (1) Annual Report.1 day ago
Reg. 34 (1) Annual Report.1 day ago
Annual General Meeting Of The Company On Tuesday 22/September/20261 day ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.4 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.8 days ago
Announcement under Regulation 30 (LODR)-AllotmentAug 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 18, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 18, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 17, 2026
FCCB Committee Meeting On Wednesday 19-August-2026Aug 14, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2026
Announcement under Regulation 30 (LODR)-AcquisitionAug 13, 2026
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentAug 13, 2026
Announcement under Regulation 30 (LODR)-AcquisitionAug 13, 2026
Financial Results For The Quarter Ended 30/06/2026Aug 12, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Aug 10, 2026
Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026Aug 09, 2026
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jul 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Closure of Trading WindowJun 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 25, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 25, 2026
Board Meeting Outcome for Board Meeting Scheduled On Thursday 18 June 2026 CancelledJun 18, 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 18Th June 2026Jun 15, 2026
Announcement under Regulation 30 (LODR)-AllotmentJun 12, 2026
Meeting Of Warrants Committee Of The Company Scheduled On Thursday 11/June/2026 Now Postponed To Friday 12/June/2026Jun 11, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJun 10, 2026
Meeting Of Warrants Committee Of The Company On Thursday 11/June/2026Jun 08, 2026
Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Jun 05, 2026
Reply To The Email Dated 18Th May 2026 Seeking Discrepancies In Financial ResultsJun 04, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 25, 2026
Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 By Listed Entities.May 21, 2026
Outcome Of Board Meeting Held Today I.E. Thursday 21St May 2026May 21, 2026
Announcement under Regulation 30 (LODR)-AllotmentMay 21, 2026
Update on board meetingMay 18, 2026
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday 22Nd May 2026May 18, 2026
Email By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Announcement Dated 15/05/2026May 18, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 15, 2026
Board Meeting Outcome for Approval Of Upto U.S. $ 20000000 Of 8.00% Senior Unsecured Foreign Currency Convertible Bonds Due 2029 Of Sudarshan Pharma Industries LimitedMay 15, 2026
Board Meeting Intimation for Meeting To Be Held On Friday May 15 2026May 12, 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 08, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 04, 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 01, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementApr 30, 2026
Audited Financial Results For The Financial Year Ended 31-03-2026Apr 30, 2026
Board Meeting Intimation for Meeting Scheduled On Thursday April 30 2026Apr 27, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Closure of Trading WindowMar 30, 2026

Technical Indicators

RSI(14)
Neutral
58.64
ATR(14)
Less Volatile
2.15
STOCH(9,6)
Overbought
89.56
STOCH RSI(14)
Overbought
96.80
MACD(12,26)
Bullish
0.56
ADX(14)
Weak Trend
19.15
UO(9)
Bearish
67.88
ROC(12)
Uptrend And Accelerating
15.53
WillR(14)
Overbought
-6.24